【Shanghai Fosun PharmaceuticalShanghai Fosun Pharmaceutical Industries agreed to acquire a total of about 32.52% of the shares in the target company from the selling shareholders at a consideration of 1.108 billion yuan] Shanghai Fosun PharmaceuticalHKExAccording to the announcement, Shanghai Fosun Pharmaceutical Industries agreed to purchase a total of 32.52 per cent of the target company from the selling shareholders at a consideration of about 1.108 billion yuan in cash. it also intends to subscribe for a new registered capital of 47958605 yuan for the target company at a price of 2.898 billion yuan for the 100% stake in its subsidiary Yalifeng. Shanghai Fosun Pharmaceutical Industries will hold a 100% stake in Yalifeng through the target company.